University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Sandy W. Wong, MD

Sandy W. Wong, MD

Assistant Clinical Professor, Division of Hematology/Oncology, UCSF

Cancer Center Program Memberships

Hematopoietic Malignancies

Education

Brown University, BA, 5/2003, Human Biology
University of Massachusetts Medical School, MD, 5/2009, Medicine
Tufts Medical Center, 6/2012, Internal Medicine Residency
Tufts Medical Center, 6/2016, Hematology/Oncology Fellowship
Tufts Medical Center, 6/2016, Amyloidosis Fellowship


Professional Experience

  • 2012-2013
    Assistant Professor, Department of Medicine, Tufts University School of Medicine, Boston, MA
  • 2016 - present
    Assistant Clinical Professor, Division of Hematology/Oncology, UCSF, San Francisco, CA

Honors & Awards

  • 2012
    Medicine Resident of the Year, Tufts Medical Center, Department of Medicine
  • 2016
    Chan Soon-Shiong Fellow, Tufts Medical Center, Division of Hematology/Oncology

Selected Publications

  1. Wong SW, Toskic D, Warner M, Varga C, Moreno-Koehler A, Fein D, Fogaren T, Lee L, Oliver CM, Guthrie SD, Comenzo RL. Primary Amyloidosis With Renal Involvement: Outcomes in 77 Consecutive Patients at a Single Center. Clin Lymphoma Myeloma Leuk. 2017 Jun 17.
    View on PubMed
  2. Wong SW, Larivee D, Warner M, Sprague KA, Fogaren T, Comenzo RL. Stem cell transplantation in patients with systemic AL amyloidosis referred for transplant after suboptimal responses to bortezomib-based initial therapy. Bone Marrow Transplant. 2017 Jun; 52(6):936-937.
    View on PubMed
  3. Sandy W. Wong, Melissa Warner, Alejandro Moreno-Koehler, Athena Kritharis, Michael E. Coyle, Deborah Black, Valerie Relias, Terry Fogaren, Nancy Cody Lyons, Francois Toka, Denise Larivee, Andrew M. Evens, Grace Kao, Kellie Sprague, Andreas K. Klein, Kenneth B. Miller, Raymond L. Comenzo. Toxicities, response and survival: Autologous stem cell transplantation for multiple myeloma over 25 years at a single center. Cancer Treatment and Research Communications. 2017; 11:1-5.
    View on PubMed
  4. Ma X, Zhou P, Wong SW, Warner M, Chaulagain C, Comenzo RL. siRNA targeting the ? light chain constant region: preclinical testing of an approach to nonfibrillar and fibrillar light chain deposition diseases. Gene Ther. 2016 Oct; 23(10):727-733.
    View on PubMed
  5. Weiss BM, Wong SW, Comenzo RL. Beyond the plasma cell: emerging therapies for immunoglobulin light chain amyloidosis. Blood. 2016 May 12; 127(19):2275-80.
    View on PubMed
  6. Wong SW, Comenzo RL. CD38 Monoclonal Antibody Therapies for Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2015 Nov; 15(11):635-45.
    View on PubMed
  7. Yuan Z, Liu X, Wong S, Machan JT, Chung MA. MUC1 Knockdown With RNA Interference Inhibits Pancreatic Cancer Growth. J Surg Res. 2009 Nov; 157(1):e39-46.
    View on PubMed
  8. Yuan Z, Wong S, Borrelli A, Chung MA. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation. Biochem Biophys Res Commun. 2007 Oct 26; 362(3):740-6.
    View on PubMed
  9. Shaw MH, Boyartchuk V, Wong S, Karaghiosoff M, Ragimbeau J, Pellegrini S, Muller M, Dietrich WF, Yap GS. A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity. Proc Natl Acad Sci U S A. 2003 Sep 30; 100(20):11594-9.
    View on PubMed

Go to UCSF Profiles, powered by CTSI